Key Dates

Related Announcements

• June 20, 2023 - Notice of Change to Funding Opportunity: Novel Insights through Cross-Site Analyses of Existing RADx-UP Data (R21 Clinical Trial Not Allowed).  See Notice NOT-OD-23-141
• May 17, 2023 - Notice of NEI Participation in RFA-OD-23-051, "Emergency Award: RADx-UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional)". See Notice NOT-EY-23-007
• May 2, 2023 - Emergency Award: Novel Insights through Cross-Site Analyses of Existing RADx-UP Data (R21 Clinical Trial Not Allowed). See Notice RFA-OD-23-050.
• May 2, 2023 - Emergency Award: RADx- UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional).  See Notice RFA-OD-23-051
• August 5, 2022 - Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.  
• August 31, 2022 - Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
• October 26, 2022 - Reminder: FORMS-H Grant Application Forms & Instructions Must be Used for Due Dates On or After January 25, 2023 - New Grant Application Instructions Now Available. See Notice NOT-OD-23-012.

Companion Funding Opportunity

RFA-OD-23-050 , R21 Exploratory/Developmental Grants 

RFA-OD-23-051 , R01 Research Project 

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This notice corrects RFA-OD-23-051  RADx- UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional) to remove the emergency designation, extend the application due date, project period, and the review and award cycle dates.

Changes to the notice of funding opportunity (NOFO) are shown below:

Currently reads:

Title of funding opportunity:

Emergency Award: RADx- UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional)

Key dates:

Application due dates: July 10, 2023

Review and award cycles:

Scientific Review Merit: August 2023

Advisory Council Review: Not Applicable

Earliest Start Date: September 2023

Expiration date: July 11, 2023

Section II. Award Information

Funds Available and Anticipated Number of Awards: The number of awards is contingent upon availability of funding and the submission of a sufficient number of meritorious applications. NIH estimates a commitment of the following amounts in FY 2024: $3,000,000-11,000,000, 1-4 awards. Awards may be multi-year funded.

Award Project Period: The maximum project period is three years.

Section IV. Application and Submission Information

6. Funding Restrictions: Awards issued under this NOFO may be incrementally funded awards for each budget period with a project period of  3 years . NIH will not issue any awards under this NOFO for a single budget period for multiple years. Project periods of greater than three years are not allowed.

Modified to Read (changes shown in bold italics):

Title of funding opportunity:

RADx- UP Dissemination and Implementation (D&I) Research on COVID-19 Testing Interventions among Underserved and Vulnerable Populations (R01 Clinical Trial Optional)

Key dates:

Application due dates: August 10, 2023

Review and award cycles:

Scientific Review Merit: January 2024

Advisory Council Review: May 2024

Earliest Start Date:   June 2024

Expiration date: August 11, 2023

Section II. Award Information

Funds Available and Anticipated Number of Awards: The number of awards is contingent upon availability of funding and the submission of a sufficient number of meritorious applications. NIH estimates a commitment of the following amounts in FY 2024: $3,000,000-11,000,000, 1-4 awards.

Award Project Period: The maximum project period is four years. 

Section IV. Application and Submission Information

6. Funding Restrictions:

All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

Pre-award costs are allowable only as described in the NIH Grants Policy Statement.

Inquiries

Please direct all inquiries to:

Ray Jacobson, PhD
Center of Scientific Review (CSR)
301-451-3409
jacobsonrh@csr.nih.gov